2015
DOI: 10.1038/srep18437
|View full text |Cite
|
Sign up to set email alerts
|

Evolution of cellular morpho-phenotypes in cancer metastasis

Abstract: Intratumoral heterogeneity greatly complicates the study of molecular mechanisms driving cancer progression and our ability to predict patient outcomes. Here we have developed an automated high-throughput cell-imaging platform (htCIP) that allows us to extract high-content information about individual cells, including cell morphology, molecular content and local cell density at single-cell resolution. We further develop a comprehensive visually-aided morpho-phenotyping recognition (VAMPIRE) tool to analyze irr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
107
0
2

Year Published

2017
2017
2021
2021

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 103 publications
(111 citation statements)
references
References 52 publications
2
107
0
2
Order By: Relevance
“…Previous studies have linked heterogeneity of cell shape to metastatic potential. For example, lower variation in morphology is predictive of cells derived from metastatic sites, but not associated with any particular somatic mutations (27). In addition, the dynamics of breast cancer cell shape heterogeneity can impact response to therapy.…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies have linked heterogeneity of cell shape to metastatic potential. For example, lower variation in morphology is predictive of cells derived from metastatic sites, but not associated with any particular somatic mutations (27). In addition, the dynamics of breast cancer cell shape heterogeneity can impact response to therapy.…”
Section: Discussionmentioning
confidence: 99%
“…High-content imaging of cancer cell lines in response to drug treatment is a standard assay applied in preclinical studies for identification of different mechanisms of drug action [9,10,11,12]. The main criteria in every morphophenotypic screen for early drug discovery is the selection of biomarkers and detection modalities (antibodies, chemical and enzymatic probes, reporter detection tags).…”
Section: Introductionmentioning
confidence: 99%
“…A candidate for this proposal is the work of Yin et al [37] where a Support Vector Machine (SVM), a supervised machine learning model, was used to identify discrete shapes from 211 geometric and texture properties of each segmented Drosphilia Kc cell. Another example is the work of Wu et al [38] with their image analysis tool VAMPIRE. The tool reduces the morphological description for an outline into similar modes of shape using PCA before analysing their distribution in cancer metastasis.…”
Section: Discussionmentioning
confidence: 99%